At Day 3, after ex vivo stimulation, PBMCs from SLE patients showed significantly higher percentages of IL-17+ CD8+ T cells than controls (P = 0.0007) but no difference from controls in percentages of CD4+ IL-17+ cells (Figure 3b). Here, CD4 is linked to systemic lupus erythematosus.